MODEL VERDICT
AngioDynamics, Inc. (ANGO)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | MODERATE | 0.62 | $11.16 | CURRENT | — |
| Apr 24, 2026 | MODERATE | 0.62 | $11.10 | CURRENT | — |
| Apr 17, 2026 | MODERATE | 0.62 | $10.86 | CURRENT | — |
| Apr 16, 2026 | MODERATE | 0.62 | $10.34 | CURRENT | — |
| Apr 10, 2026 | MODERATE | 0.62 | $9.80 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 8 industry peers | $23.38 | +109.5% | 4% | B | Data |
| Price / Sales 8 industry peers | $20.82 | +86.6% | 3% | B | Model Driven |
| Weighted Output Blended model output | $19.10 | +71.1% | 100% | 58 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 6.90 | 4.93 | 2.87 | 15.29 | 4.53 |
| P/B Ratio | 1.63 | 1.28 | 0.82 | 2.88 | 0.77 |
| P/S Ratio | 1.88 | 1.70 | 0.91 | 3.63 | 0.88 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates ANGO's fair value at $19.10 vs the current price of $11.16, implying +71.1% upside potential. Model verdict: Significantly Undervalued. Confidence: 58/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $19.10 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $16.16 (P10) to $25.83 (P90), with a median of $20.97.
ANGO's current P/E of -13.4x compares to the industry median of 26.9x (6 peers in the group). This represents a -150.0% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
11 analysts cover ANGO with a consensus rating of Hold. The consensus price target is $16.50 (range: $12.00 — $22.00), implying +47.8% upside from the current price. Grade breakdown: Strong Buy (0), Buy (5), Hold (6), Sell (0), Strong Sell (0).
The model confidence score is 58/100, based on: data completeness (6), peer quality (25), historical depth (20), earnings stability (5), and model agreement (2). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for ANGO.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.